Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

From Local Evidence to Regional Leadership: Post-Preeclampsia Care in Thailand.

Created on 11 Oct 2026

Authors

Nam Hoang Tran, Kanchana Piboon

Published in

International journal of women's health. Volume 18. Pages 645203. Epub Oct 06, 2026.

Abstract

Hypertensive disorders of pregnancy, particularly preeclampsia, identify women at increased risk of persistent hypertension and later cardiovascular disease, yet postpartum services often remain organized around short-term obstetric recovery. Thailand is well positioned to address this discontinuity because prospective local studies have demonstrated elevated blood pressure, hypertension, and selected cardiovascular and renal risk markers at 6 weeks and 6-12 months after preeclampsia or gestational hypertension. The principal policy gap is therefore not the absence of warning evidence, but the lack of a standardized and auditable handover from maternity services to primary care and cardiovascular prevention. This commentary was informed by a targeted, non-systematic examination of peer-reviewed studies, international professional recommendations, World Health Organization resources, and publicly accessible national guidance available in English through June 2026. Evidence was selected to characterize longer-term cardiovascular and renal risk following hypertensive disorders of pregnancy, summarize relevant Thai postpartum findings, and identify regional health-system approaches that could inform continuity of care in Thailand. Vietnam, Malaysia, and Mongolia were purposively selected as complementary examples of community noncommunicable-disease integration, local-clinic follow-up after hypertensive pregnancy, and continuity of care across geographic distance, respectively. We propose a standardized multicenter pilot comprising documented risk communication and a named receiving provider before discharge; blood-pressure evaluation within 72 hours for women with severe hypertension and no later than 7-10 days for other women with hypertensive disorders; structured assessment at 6-12 weeks and 6-12 months; permanent recording of hypertensive pregnancy history; and annual cardiovascular-risk review. National scale-up should follow evaluation of feasibility, completion, equity, and clinical outcomes. The aim is not to create a parallel specialty service, but to convert an established obstetric warning sign into accountable long-term cardiovascular and renal prevention.

PMID:
42859661
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement